The safety and regulation of natural products used as foods and food ingredients.

The use of botanicals and dietary supplements derived from natural substances as an adjunct to an improved quality of life or for their purported medical benefits has become increasingly common in the United States. This review addresses the safety assessment and regulation of food products containing these substances by the U.S. Food and Drug Administration (FDA). The issue of safety is particularly critical given how little information is available on the toxicity of some of these products. The first section uses case studies for stevia and green tea extracts as examples of how FDA evaluates the safety of botanical and herbal products submitted for consideration as Generally Recognized as Safe under the Federal Food, Drug, and Cosmetics Act. The 1994 Dietary Supplement Health Education Act (DSHEA) created a regulatory framework for dietary supplements. The article also discusses the regulation of this class of dietary supplements under DSHEA and addresses the FDA experience in analyzing the safety of natural ingredients described in pre-market safety submissions. Lastly, we discuss an ongoing interagency collaboration to conduct safety testing of nominated dietary supplements.

[1]  M. Sanders,et al.  The science and regulations of probiotic food and supplement product labeling , 2011, Annals of the New York Academy of Sciences.

[2]  Joseph M. Betz,et al.  Dietary supplement use in the United States, 2003-2006. , 2011, The Journal of nutrition.

[3]  T. Dadd,et al.  The impact of the catechol-O-methyltransferase genotype on the acute responsiveness of vascular reactivity to a green tea extract , 2010, British Journal of Nutrition.

[4]  A. Chandra,et al.  Goitrogenic/antithyroidal potential of green tea extract in relation to catechin in rats. , 2010, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[5]  J. Heimbach,et al.  Safety assessment of probiotics for human use , 2010, Gut microbes.

[6]  R. Kuttan,et al.  Beneficial effects of green tea: A literature review , 2010, Chinese medicine.

[7]  E. Riedmann,et al.  Exciting times for gastrointestinal microbiology , 2010, Gut microbes.

[8]  E. Ernst,et al.  Green tea (Camellia sinensis) for the prevention of cancer. , 2009, The Cochrane database of systematic reviews.

[9]  G. Mazzanti,et al.  Hepatotoxicity from green tea: a review of the literature and two unpublished cases , 2009, European Journal of Clinical Pharmacology.

[10]  A. Thierry,et al.  Safety assessment of dairy microorganisms: Propionibacterium and Bifidobacterium. , 2008, International journal of food microbiology.

[11]  Sean M Hays,et al.  Biomonitoring Equivalents (BE) dossier for 2,4-dichlorophenoxyacetic acid (2,4-D) (CAS No. 94-75-7). , 2008, Regulatory toxicology and pharmacology : RTP.

[12]  G. Klein,et al.  Safety aspects and implications of regulation of probiotic bacteria in food and food supplements. , 2008, Journal of food protection.

[13]  F. Debellé,et al.  Aristolochic acid nephropathy: a worldwide problem. , 2008, Kidney international.

[14]  N. Brown,et al.  Rebaudioside A: two-generation reproductive toxicity study in rats. , 2008, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[15]  Ashley Nicole Roberts,et al.  Subchronic toxicity of rebaudioside A. , 2008, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[16]  J. Mckenney,et al.  The hemodynamic effects of rebaudioside A in healthy adults with normal and low-normal blood pressure. , 2008, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[17]  A. Wheeler,et al.  Pharmacokinetics of rebaudioside A and stevioside after single oral doses in healthy men. , 2008, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[18]  A. Renwick,et al.  Comparative toxicokinetics and metabolism of rebaudioside A, stevioside, and steviol in rats. , 2008, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[19]  L. Barriocanal,et al.  Apparent lack of pharmacological effect of steviol glycosides used as sweeteners in humans. A pilot study of repeated exposures in some normotensive and hypotensive individuals and in Type 1 and Type 2 diabetics. , 2008, Regulatory toxicology and pharmacology : RTP.

[20]  A. Eapen,et al.  A 90-Day Oral (Dietary) Toxicity Study of Rebaudioside A in Sprague-Dawley Rats , 2008, International journal of toxicology.

[21]  B. Jelaković,et al.  Role of environmental toxins in endemic (Balkan) nephropathy. October 2006, Zagreb, Croatia. , 2007, Journal of the American Society of Nephrology : JASN.

[22]  M. Bernardeau,et al.  Beneficial lactobacilli in food and feed: long-term use, biodiversity and proposals for specific and realistic safety assessments. , 2006, FEMS microbiology reviews.

[23]  R. Isbrucker,et al.  Safety studies on epigallocatechin gallate (EGCG) preparations. Part 2: dermal, acute and short-term toxicity studies. , 2006, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[24]  Reyes Artacho,et al.  Beneficial Effects of Green Tea—A Review , 2006, Journal of the American College of Nutrition.

[25]  P. O'Brien,et al.  Cellular and in vivo hepatotoxicity caused by green tea phenolic acids and catechins. , 2006, Free radical biology & medicine.

[26]  D. Alberts,et al.  Effects of Dosing Condition on the Oral Bioavailability of Green Tea Catechins after Single-Dose Administration of Polyphenon E in Healthy Individuals , 2005, Clinical Cancer Research.

[27]  H. Babich,et al.  In vitro cytotoxicity of epigallocatechin gallate and tea extracts to cancerous and normal cells from the human oral cavity. , 2004, Basic & clinical pharmacology & toxicology.

[28]  Dietary Supplements Containing Ephedrine Alkaloids Adulterated Because They Present an Unreasonable Risk; Final Rule , 2004, Journal of pain & palliative care pharmacotherapy.

[29]  B. Tomlinson,et al.  Efficacy and tolerability of oral stevioside in patients with mild essential hypertension: a two-year, randomized, placebo-controlled study. , 2003, Clinical therapeutics.

[30]  P. Vereerstraeten,et al.  Progression rate of Chinese herb nephropathy: impact of Aristolochia fangchi ingested dose. , 2002, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[31]  C. DesRoches,et al.  Americans' views on the use and regulation of dietary supplements. , 2001, Archives of internal medicine.

[32]  M. Melis,et al.  Effects of chronic administration of Stevia rebaudiana on fertility in rats. , 1999, Journal of ethnopharmacology.

[33]  G. Lucier,et al.  Medicinal herbs in the United States: research needs. , 1999, Environmental health perspectives.

[34]  S. Musser,et al.  Contamination of botanical dietary supplements by Digitalis lanata. , 1998, The New England journal of medicine.

[35]  K. Toyoda,et al.  Assessment of the carcinogenicity of stevioside in F344 rats. , 1997, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[36]  Mélis Ms A CRUDE EXTRACT OF STEVIA REBAUDIANA INCREASES THE RENAL PLASMA FLOW OF NORMAL AND HYPERTENSIVE RATS , 1996 .

[37]  C. van Ypersele de Strihou,et al.  Detection of DNA adducts formed by aristolochic acid in renal tissue from patients with Chinese herbs nephropathy. , 1996, Cancer research.

[38]  M. Melis Chronic administration of aqueous extract of Stevia rebaudiana in rats: renal effects. , 1995, Journal of ethnopharmacology.

[39]  J L Vanherweghem,et al.  Pathologic aspects of a newly described nephropathy related to the prolonged use of Chinese herbs. , 1994, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[40]  C van Ypersele de Strihou,et al.  Chinese herbs nephropathy: a clue to Balkan endemic nephropathy? , 1994, Kidney international.

[41]  J. Elford,et al.  Psychology and survival , 1994, The Lancet.

[42]  P. But,et al.  Identification of aristolochic acid in Chinese herbs , 1994, The Lancet.

[43]  M. Jadoul,et al.  Rapidly progressive interstitial renal fibrosis in young women: association with slimming regimen including Chinese herbs , 1993, The Lancet.

[44]  J. Gleye,et al.  Antibacterial activity of the leaves of Phyllanthus discoideus. , 1990, Journal of ethnopharmacology.

[45]  J. Kuc,et al.  Contraceptive Properties of Stevia rebaudiana , 1968, Science.

[46]  Tribe De,et al.  Choice of Diet by Rats , 1955, British Journal of Nutrition.

[47]  V. Arlt,et al.  Chemical and molecular basis of the carcinogenicity of Aristolochia plants. , 2009, Current opinion in drug discovery & development.

[48]  G. Mahady,et al.  Safety of Green Tea Extracts , 2008, Drug safety.

[49]  A. von Wright Regulating the safety of probiotics--the European approach. , 2005, Current pharmaceutical design.

[50]  A. Vandewalle Diversity within the CLC chloride channel family involved in inherited diseases: from plasma membranes to acidic organelles. , 2002, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[51]  A. Kinghorn,et al.  Stevia: the genus Stevia. , 2002 .

[52]  J. Vanherweghem,et al.  Misuse of herbal remedies: the case of an outbreak of terminal renal failure in Belgium (Chinese herbs nephropathy) , 1998, Journal of alternative and complementary medicine.

[53]  M. Melis A crude extract of Stevia rebaudiana increases the renal plasma flow of normal and hypertensive rats. , 1996, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[54]  EINZ,et al.  UROTHELIAL CARCINOMA ASSOCIATED WITH THE USE OF A CHINESE HERB ( ARISTOLOCHIA FANGCHI ) , 2022 .